Metabolic syndrome is characterized by the clustering of several metabolic abnormalities frequently observed in clinical practice:

Abdominal obesity, dyslipidaemia, hyperinsulinemia, impaired fasting glucose, and high blood pressure, according to the International Diabetes Federation, the American Heart Association, and the National Heart, Lung, and Blood Institute harmonizing definition.

In a prospective cohort study done on middle-aged healthy men, Metabolic Syndrome was associated with cardiovascular disease and mortality, and a published meta-analysis of longitudinal studies revealed an association between Metabolic Syndrome and a higher risk of developing type 2 diabetes mellitus, cardiovascular disease, atherosclerosis, and higher all-cause mortality. Due to the existence of different definitions for diagnosing this syndrome, prevalence estimates vary. However, it is accepted that the prevalence of Metabolic Syndrome generally increases as body mass index and age increase. In developed countries, the prevalence of Metabolic Syndrome is about 25% of the adult population, and its incidence has been increasing over the last years leading to the requirement of metabolic disorder treatment in Pune, India. Genetics cannot explain these differences alone, and environmental influences play an important role. Several articles have shown the association between different lifestyle habits and the risk of developing Metabolic Syndrome according to the harmonizing definition. In this context, eating habits are considered modifiable determinants of Metabolic Syndrome.